HLS Therapeutics Inc. (TSE:HLS – Get Rating) declared a quarterly dividend on Wednesday, March 15th, Zacks reports. Stockholders of record on Friday, April 28th will be given a dividend of 0.05 per share on Thursday, June 15th. This represents a $0.20 annualized dividend and a dividend yield of 2.79%. The ex-dividend date of this dividend is Thursday, April 27th.
HLS Therapeutics Stock Down 16.0 %
HLS Therapeutics stock opened at C$7.18 on Friday. The company has a quick ratio of 1.01, a current ratio of 1.46 and a debt-to-equity ratio of 75.85. The company has a market capitalization of C$232.49 million, a PE ratio of -7.72 and a beta of 0.86. The firm’s fifty day moving average is C$9.08 and its 200 day moving average is C$9.48. HLS Therapeutics has a 12-month low of C$6.79 and a 12-month high of C$15.59.
HLS Therapeutics Company Profile
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
- Europe Raises Interest Rates, Should the Fed Follow?
- PacWest Bancorp May Escape a Credit Downgrade After this Happens
- Dollar General Offers Great Prices, but the Stock isn’t a Value
Receive News & Ratings for HLS Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HLS Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.